|
Dr. Mayer has played a lead role in the discovery and development of a number of anti-cancer drugs. He held senior management positions at The Canadian Liposome Company and QLT Inc. before joining the BC Cancer Agency, where he directed the Investigational Drug Program. He is currently also adjunct professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia. Dr. Mayer has published more than 120 scientific articles and has been awarded 10 patents related to his research. Dr. Mayer received his B.S. in both Chemistry and Biology (1978), summa cum laude, from Wartburg College and his Ph.D. in Biochemistry (1983) from the University of Minnesota. | 